Differential Diagnosis Considered etiologies included: Primary psychiatric disorder Neuroinflammatory or neurodegenerative disease Endocrine dysfunction Chronic infection (Lyme disease, EBV) Chronic inflammatory response syndrome (CIRS) Environmental toxin exposure (including mycotoxins) The acute onset, lack of psychiatric history, and environmental correlation made a primary psychiatric etiology less likely
| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials
Drugs Dermatol
Due to their delivery route, oral peptides, like Healthletics Arginine Salt formulation, are often highlighted for this type of support
Building your personalised GHK-Cu protocol in Mumbai A workable GHK-Cu protocol comes from six clean steps: Define the goal - skin, hair, healing, longevity or a combination Choose the route - injectable, topical, oral, or a combination Set the starting dose - conservative end of the range for your goal Set the schedule - daily, 5-on/2-off, or 3/week
A subsequent investigation corroborated similar findings